Intervacc Q2:
Net sales 1.9 M (SEK)
Operating loss -18 M
Net loss for the period -18 M
To put it plainly, a total fiasco. International sales of the miracle vaccine are a ridiculous 160 thousand euros, which is on the same level as the turnover of some local car repair shop in Kajaani.
Yet the company’s market value is still 26 M euros. I don’t understand…